Uric Acid Correlates with Serum Levels of Mineral Bone Metabolism and Inflammation Biomarkers in Patients with Stage 3a–5 Chronic Kidney Disease
<i>Background and Objectives</i>: Uric acid (UA) and the markers of mineral bone metabolism and inflammation are commonly altered in patients with chronic kidney disease (CKD) and are associated with the risk of cardiovascular complications and death. Studies point to a link between high...
Saved in:
| Main Authors: | Francisco Mendoza Carrera, Gloria Elizabeth Vázquez Rivera, Caridad A. Leal Cortés, Lourdes del Carmen Rizo De la Torre, Renato Parra Michel, Rosalba Orozco Sandoval, Mariana Pérez Coria |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/12/2081 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study
by: Tugba Islek, et al.
Published: (2024-11-01) -
The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01) -
The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
by: Laurence Ferrières, et al.
Published: (2025-06-01) -
Evaluation of fibroblast growth factor 23 as a marker of severity in stable chronic obstructive pulmonary disease
by: Simarpreet Singh, et al.
Published: (2025-06-01) -
Expression of fibroblast growth factor 23 (FGF23) and αKlotho in two commercial laying hen strains fed with and without dietary mineral P supplements before and after the onset of the laying phase
by: Leonie Meier, et al.
Published: (2025-11-01)